98 related articles for article (PubMed ID: 6994194)
21. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
22. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
23. [Function of prostaglandins in platelet aggregation].
Sun QW
Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620
[No Abstract] [Full Text] [Related]
24. [Anti-platelet aggregation effect of PGI2 potentiated by EG-626].
Tanaka K; Harada Y; Katori M
Rinsho Byori; 1979; Suppl 40():188-91. PubMed ID: 399308
[No Abstract] [Full Text] [Related]
25. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
[No Abstract] [Full Text] [Related]
26. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
27. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
Baluda VP; Sushkevich GN; Lukoianova TI
Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
[No Abstract] [Full Text] [Related]
28. Synergism between prostacyclin (PGI2) and prazosin on human platelet aggregation.
Moore PK
Thromb Haemost; 1982 Feb; 47(1):76. PubMed ID: 7041326
[No Abstract] [Full Text] [Related]
29. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
[TBL] [Abstract][Full Text] [Related]
30. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
31. Synergic effect of prostacyclin (PGI2) and alpha-blocking-agent on adrenalin-induced human platelet aggregation.
Pogliani E; Fantasia R; Colombi M; Praga C
Thromb Haemost; 1980 Oct; 44(2):106. PubMed ID: 6109380
[No Abstract] [Full Text] [Related]
32. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada S; Vane JR
Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
[No Abstract] [Full Text] [Related]
33. Prostaglandins and thromboxanes: biochemical and physiological considerations.
Samuelsson B; Folco G; Granström E; Kindahl H; Malmsten C
Adv Prostaglandin Thromboxane Res; 1978; 4():1-25. PubMed ID: 347910
[No Abstract] [Full Text] [Related]
34. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
[No Abstract] [Full Text] [Related]
35. Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma.
Dembinska-Kiec A; Rücker W; Schönhöfer PS; Gandolfi C
Thromb Haemost; 1979 Dec; 42(4):1340-3. PubMed ID: 232318
[No Abstract] [Full Text] [Related]
36. [Prostacyclin--inhibitory effect on thrombocyte aggregation on the vascular wall in vivo?].
Sinzinger H; Silberbauer K; Winter M
Vasa; 1978; 7(4):350-9. PubMed ID: 364866
[No Abstract] [Full Text] [Related]
37. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction.
Jørgensen KA
Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257
[No Abstract] [Full Text] [Related]
38. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
[TBL] [Abstract][Full Text] [Related]
39. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
Herman AG
Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
[No Abstract] [Full Text] [Related]
40. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
